文献速递功能神经外科

新型8触点电极恒流苍白球内侧部脑深部电刺激治疗原发性肌张力障碍

Constant-Current Deep Brain Stimulation of the Globus Pallidus Internus in the Treatment of Primary Dystonia by a Novel 8-Contact (Octrode) Lead.
PubMed 文献 · World Neurosurg · 2017-03-28

这项前瞻性、开放标签、单中心先导研究纳入10例原发性肌张力障碍患者,评估新型8通道电极双侧恒流苍白球内侧部脑深部电刺激的可行性。6个月随访时6例(60.0%)Burke-Fahn-Marsden肌张力障碍评定量表评分较基线降低>50%被归为应答者,其中5例(83.3%)应答维持至第一年末。恒流刺激与所有患者疼痛和生活质量显著改善相关,运动评分改善54%,大部分在第一个月内出现。

要点

  • 6个月随访时6例(60.0%)BFMDRS评分较基线降低>50%,归为应答者。
  • 6例应答者中5例(83.3%)应答维持至第一年末评估。
  • 运动评分改善54%,近84%的整体改善在刺激开始后第一个月内出现。

核心结论

  • 恒流苍白球内侧部脑深部电刺激被证明对原发性肌张力障碍的治疗安全有效。
  • 运动评分改善54%,大部分在第一个月内。
  • 尽管新电极能够刺激苍白球内侧部内的特定位点,但未能实现表型特异性刺激。

研究设计与样本

  • 前瞻性、开放标签、单中心先导研究,纳入10例原发性肌张力障碍患者,评估新型8通道电极双侧恒流苍白球内侧部脑深部电刺激的可行性,以标准量表为结局指标。

主要发现

  • 患者包括4例男性和6例女性,平均年龄35.8岁±9.2(范围27-49岁)。
  • 平均发病年龄18.5岁±9.1(范围8-35岁),平均病程17.3年(范围7-27年)。
  • 所有患者均为原发性肌张力障碍(8例全身型肌张力障碍,1例节段型肌张力障碍,1例局灶型肌张力障碍)。
  • 6例患者(60.0%)在6个月随访时Burke-Fahn-Marsden肌张力障碍评定量表评分较基线降低>50%,被归为应答者。
  • 这6例应答者中5例(83.3%)应答维持至第一年末评估;恒流刺激与所有患者疼痛和生活质量显著改善相关;近84%的整体改善在刺激开始后第一个月内出现;轴性症状反应最佳。

关键数值与推荐

  • 主要变量定义为6个月随访时Burke-Fahn-Marsden肌张力障碍评定量表评分较基线降低50%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate bilateral constant-current globus pallidus internus (GPi) deep brain stimulation using an 8-contact lead. METHODS: This prospective, open-label, single-center pilot study of 10 patients assessed the feasibility of delivering bilaterally constant-current GPi deep brain stimulation with a novel 8-channel lead to treat primary dystonia using standard scales as outcome measures. RESULTS: Patients included 4 men and 6 women with a mean age of 35.8 years ± 9.2 (range, 27-49 years). Mean age of onset was 18.5 years ± 9.1 (range, 8-35 years), and mean disease duration was 17.3 years (range, 7-27 years). All had primary dystonia (8 generalized dystonia, 1 segmental dystonia, 1 focal dystonia). The primary variable was determined as 50% reduction in dystonia symptoms from baseline to the 6-month follow-up, as defined by the Burke-Fahn-Marsden Dystonia Rating Scale. Six patients (60.0%) achieved >50% reduction in Burke-Fahn-Marsden Dystonia Rating Scale score and were classified as responders at the 6-month follow-up. Five of these 6 responders (83.3%) sustained that response through the assessment at the end of the first year. Constant-current stimulation was associated with significant improvement in pain and quality of life in all patients. Nearly 84% of the overall improvement occurred by the end of first month after stimulation onset, documenting an early response to treatment. Axial symptoms responded the best. CONCLUSIONS: Constant-current GPi deep brain stimulation proved safe and efficacious for treatment of primary dystonia. Motor scores improved by 54%, mostly within the first month. No phenotype-specific stimulation could be achieved, despite the capability of the new lead to stimulate specific loci within the GPi.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sakas DE, Leonardos A, Boviatsis E, et al. Constant-Current Deep Brain Stimulation of the Globus Pallidus Internus in the Treatment of Primary Dystonia by a Novel 8-Contact (Octrode) Lead. World Neurosurg. 2017. PMID: 28363831. doi:10.1016/j.wneu.2017.03.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。